Gatault, Philippe <br/><br/>
Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule.  [electronic resource] 

 -  mAbs  2015 
 - 1205-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1942-0870 
<br/><br/><label>Standard No.: </label>10.1080/19420862.2015.1086049  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Atypical Hemolytic Uremic Syndrome--drug therapy<br/>Body Weight<br/>Dose-Response Relationship, Drug<br/>Drug Monitoring--methods<br/>Female<br/>Half-Life<br/>Hemoglobinuria, Paroxysmal--drug therapy<br/>Humans<br/>Maintenance Chemotherapy<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Pilot Projects<br/>Precision Medicine--methods<br/>Retrospective Studies<br/>Young Adult